(Press-News.org) Bottom Line: States that implemented medical marijuana laws appear to have lower annual opioid analgesic overdoses death rates (both from prescription pain killers and illicit drugs such as heroin) than states without such laws although the reason why is not clear.
Author: Marcus A. Bachhuber, M.D., of the Philadelphia Veterans Affairs Medical Center, and colleagues.
Background: Prescriptions for opioid painkillers for chronic pain have increased in the United States and so have overdose deaths. However, less attention has been focused on how the availability of alternative nonopioid treatment, such as medical marijuana, may affect overdose rates.
How the Study Was Conducted: The authors examined the implementation of state medical marijuana laws and opioid analgesic overdose deaths in the United States between 1999 and 2010. Three states had medical marijuana laws prior to 1999, 10 states implemented laws between 1999 and 2010 and nine states had laws that went into effect after 2010, which was beyond the study period. The authors also considered New Jersey's law effective after the study period because it took effect in the last quarter of 2010. The authors analyzed state laws and death-certificate data.
Results: States with medical marijuana laws had a 24.8 percent lower average annual opioid overdose death rate compared to states without such laws. In 2010, that translated to about 1,729 fewer deaths than expected. The years after implementation of medical marijuana laws also were associated with lower overdose death rates that generally got stronger over time: year 1 (-19.9 percent), year 2 (-25.2 percent), year 3 (-23.6 percent), year 4 (-20.2 percent), year 5 (-33.7 percent) and year 6 (-33.3 percent).
Discussion: "In summary, although we found a lower mean annual rate of opioid analgesic mortality in states with medical cannabis laws, a direct causal link cannot be established. … If the relationship between medical cannabis laws and opioid analgesic overdose mortality is substantiated in further work, enactment of laws to allow for use of medical cannabis may be advocated as part of a comprehensive package of policies to reduce the population risk of opioid analgesics."
(JAMA Intern Med. Published online August 25, 2014. doi:10.1001/jamainternmed.2014.4005. Available pre-embargo to the media at http://media.jamanetwork.com.)
Editor's Note: An author made a conflict of interest disclosure. This work was funded by National Institutes of Health grants and the Center for AIDS Research at the Albert Einstein College of Medicine and Montefiore Medical Center. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Commentary: Legalization of Medical Marijuana and Incidence of Opioid Mortality
In a related commentary, Marie J. Hayes, Ph.D., of the University of Maine, Orno, and Mark S. Brown, M.D., of the Eastern Maine Medical Center, Bangor, write: "If medical marijuana laws afford a protective effect, it is not clear why. If the decline in opioid analgesic-related overdose deaths is explained, as claimed by the authors, by increased access to medical marijuana as an adjuvant medication for patients taking prescription opioids, does this mean that marijuana provides improved pain control that decreases opioid dosing to safer levels?"
"The potential protective role of medical marijuana in opioid analgesic-associated mortality and its implication for public policy is a fruitful area for future work," they conclude.
(JAMA Intern Med. Published online August 18, 2014. doi:10.1001/jamainternmed.2014.2716. Available pre-embargo to the media at http://media.jamanetwork.com.)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
INFORMATION:
Media Advisory: To contact author Marcus A. Bachhuber, M.D., call Katie Delach at 215-349-5964 or email katie.delach@uphs.upenn.edu. To contact commentary author Marie J. Hayes, Ph.D., call Margaret Nagle at 207-581-3745 or email nagle@maine.edu.
To place an electronic embedded link to this study in your story: Links for this study and commentary will be live at the embargo time: http://archinte.jamanetwork.com/article.aspx?doi=10.1001/jamainternmed.2014.4005 and http://archinte.jamanetwork.com/article.aspx?doi=10.1001/jamainternmed.2014.2716.
Lower opioid overdose death rates associated with state medical marijuana laws
2014-08-25
ELSE PRESS RELEASES FROM THIS DATE:
Weekend hospitalization linked to longer stay for pediatric leukemia patients
2014-08-25
Bottom Line: Weekend admission to the hospital for pediatric patients newly diagnosed with leukemia was associated with a longer length of stay, slightly longer wait to start chemotherapy and higher risk for respiratory failure but weekend admissions were not linked to an increased risk for death.
Author: Elizabeth K. Goodman, B.A., of the Children's Hospital of Philadelphia, and colleagues.
Background: Leukemia is a common childhood cancer that accounts for about 30 percent of all pediatric cancer diagnoses. Previous research has indicated an increased risk of death ...
Complication risk of deep brain stimulation similar for older, younger Parkinson patients
2014-08-25
Bottom Line: Older patients with Parkinson disease (PD) who undergo deep brain stimulation (DBS) appear to have a 90-day complication risk similar to younger patients, suggesting that age alone should not be a primary factor for excluding patients as DBS candidates.
Author: Michael R. DeLong, B.A., of the Duke University Medical Center, Durham, N.C., and colleagues.
Background: For patients with advanced PD who have involuntary movements, DBS has been found to be an effective treatment for reducing motor disability and improving quality of life. Recent studies suggest ...
Two case reports of rare stiff person syndrome
2014-08-25
Bottom Line: Two female patients achieved clinical remission from the rare, debilitating neurological disease called stiff person syndrome (SPS, which can be marked by a "tin soldier" gait) after an autologous (from your own body) stem cell transplant that eventually allowed them to return to work and regain their previous functioning.
Author: Sheilagh Sanders, M.D., of the University of Ottawa, Canada, and colleagues.
Background: SPS is a disease characterized by stiffness of the skeletal muscles, painful muscle spasms and, in severe cases, the disease can prevent ...
Study shows 25 percent fewer opioid-related deaths in states allowing medical marijuana
2014-08-25
Philadelphia – On average, states allowing the medical use of marijuana have lower rates of deaths resulting from opioid analgesic overdoses than states without such laws. Opioid analgesics, such as OxyContin, Percocet and Vicodin, are prescribed for moderate to severe pain, and work by suppressing a person's perception of pain. A new multi-institutional study, published in JAMA Internal Medicine and led by researchers at the Perelman School of Medicine at the University of Pennsylvania, examined the rate of deaths caused by opioid overdoses between 1999 and 2010. Results ...
New process helps overcome obstacles to produce renewable fuels and chemicals
2014-08-25
There's an old saying in the biofuels industry: "You can make anything from lignin except money." But now, a new study may pave the way to challenging that adage. The study from the Energy Department's National Renewable Energy Laboratory (NREL) demonstrates a concept that provides opportunities for the successful conversion of lignin into a variety of renewable fuels, chemicals, and materials for a sustainable energy economy.
"Lignin Valorization Through Integrated Biological Funneling and Chemical Catalysis" was recently published in the Proceedings of the National ...
Kite Pharma announces positive results in patients with aggressive non-Hodgkin's lymphoma
2014-08-25
12 of 13 Total Evaluable Patients with Advanced B Cell Malignancies Had Complete Remissions (8 Patients) or Partial Remissions (4 Patients) Resulting in a 92% Objective Response Rate
4 of 7 Evaluable Patients with Chemotherapy-Refractory Diffuse Large B-cell Lymphoma (DLBCL) Achieved Complete Remissions, 3 of Which Are Ongoing and 1 of Which Is Ongoing after 22 Months
The Results Have Been Published in the August 25, 2014 Issue of the American Society of Clinical Oncology's (ASCO) Journal of Clinical Oncology
The Results Support Kite's Plan to File an Investigational ...
Researchers find boron facilitates stem cell growth and development in corn
2014-08-25
COLUMBIA, Mo. – Boron deficiency is one of the most widespread causes of reduced crop yield. Missouri and the eastern half of the United States are plagued by boron deficient soil and, often, corn and soybean farmers are required to supplement their soil with boron; however, little is known about the ways in which corn plants utilize the essential nutrient. Now, researchers at the University of Missouri have found that boron plays an integral role in development and reproduction in corn plants. Scientists anticipate that understanding how corn uses the nutrient can help ...
High insulin levels tied to obesity pathway, new UT Southwestern research shows
2014-08-25
UT Southwestern Medical Center researchers have identified a crucial link between high levels of insulin and pathways that lead to obesity, a finding that may have important implications when treating diabetes.
Researchers with the UT Southwestern's Touchstone Center for Diabetes found that giving mice high levels of insulin, which is typically done to counter the effects of diabetes or insulin resistance in Type 2 diabetes, also fosters processes that lead to obesity.
The discovery was made by studying mice engineered to lack receptors for a hormone called glucagon.
Glucagon ...
Finding keys to glioblastoma therapeutic resistance
2014-08-25
Researchers at the University of California, San Diego School of Medicine have found one of the keys to why certain glioblastomas – the primary form of a deadly brain cancer – are resistant to drug therapy. The answer lies not in the DNA sequence of the tumor, but in its epigenetic signature. These findings have been published online as a priority report in the journal Oncotarget.
"There is a growing interest to guide cancer therapy by sequencing the DNA of the cancer cell," said Clark Chen, MD, PhD, vice-chairman of Research and Academic Development, UC San Diego Division ...
Gut bacteria that protect against food allergies identified
2014-08-25
The presence of Clostridia, a common class of gut bacteria, protects against food allergies, a new study in mice finds. By inducing immune responses that prevent food allergens from entering the bloodstream, Clostridia minimize allergen exposure and prevent sensitization – a key step in the development of food allergies. The discovery points toward probiotic therapies for this so-far untreatable condition, report scientists from the University of Chicago, Aug 25 in the Proceedings of the National Academy of Sciences.
Although the causes of food allergy – a sometimes deadly ...